iLABMED最新文献

筛选
英文 中文
Successful treatment of severe monkeypox case with advanced HIV infection using plasma from smallpox-vaccinated healthy population: A case report 使用接种过天花疫苗的健康人群的血浆成功治疗晚期艾滋病病毒感染的重症猴痘病例:病例报告
iLABMED Pub Date : 2024-03-10 DOI: 10.1002/ila2.32
Chuming Chen, Weiming Yao, Siran Huang, Ling Peng, Shiyan Feng, Weibo Wu, Yunlan Yi, Zhiqiang Cheng, Yang Yang, Yan Yang, Liuqing Yang, Hongzhou Lu, Fuxiang Wang
{"title":"Successful treatment of severe monkeypox case with advanced HIV infection using plasma from smallpox-vaccinated healthy population: A case report","authors":"Chuming Chen,&nbsp;Weiming Yao,&nbsp;Siran Huang,&nbsp;Ling Peng,&nbsp;Shiyan Feng,&nbsp;Weibo Wu,&nbsp;Yunlan Yi,&nbsp;Zhiqiang Cheng,&nbsp;Yang Yang,&nbsp;Yan Yang,&nbsp;Liuqing Yang,&nbsp;Hongzhou Lu,&nbsp;Fuxiang Wang","doi":"10.1002/ila2.32","DOIUrl":"10.1002/ila2.32","url":null,"abstract":"<p>Since the first reported case of monkeypox in the UK in May 2022, there has been an upward trend in monkeypox cases and a global outbreak. However, reports of severe cases are relatively limited. In this study, we report a case of severe monkeypox in a patient with HIV. The patient presented with skin lesions that started on his face and around the penis and persisted for several months. Throughout the course of the disease, he received systematic symptomatic supportive treatment, topical remedies, and special care for the rash. He also underwent cidofovir antiviral therapy and smallpox-vaccinated healthy population-derived plasma therapy in succession, with the condition ultimately showing improvement after plasma treatment. After more than 3 months of hospitalization, he fully recovered. To the best of our knowledge, this is the first reported use of smallpox-vaccinated healthy population-derived plasma in the treatment of severe monkeypox cases.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.32","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140255168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic approaches for monkeypox virus 猴痘病毒的诊断方法
iLABMED Pub Date : 2024-03-07 DOI: 10.1002/ila2.36
Guohao Fan, Jiahua Kuang, Shengjie Zhang, Yang Yang, Yingxia Liu, Hongzhou Lu
{"title":"Diagnostic approaches for monkeypox virus","authors":"Guohao Fan,&nbsp;Jiahua Kuang,&nbsp;Shengjie Zhang,&nbsp;Yang Yang,&nbsp;Yingxia Liu,&nbsp;Hongzhou Lu","doi":"10.1002/ila2.36","DOIUrl":"10.1002/ila2.36","url":null,"abstract":"<p>Mpox (formerly Monkeypox) is a zoonotic infection caused by Monkeypox virus (MPXV). Since 2022, Mpox epidemics have occurred in many non-endemic countries and regions, leading the World Health Organization to declare a public health emergency of international concern. With the persistent transmission and evolution of MPXV, symptoms of Mpox have become milder, with some infections being asymptomatic. In addition, MPXV has become more contagious. Therefore, rapid and accurate diagnosis and screening of MPXV is vital to prevent and control MPXV epidemics. Here, we review and summarize the technical details, application scenarios, and the advantages and disadvantages of MPXV-specific diagnostic methods.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.36","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140259101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From bench to bedside: Opportunities and challenges for iLABMED 从工作台到床边:iLABMED 的机遇与挑战
iLABMED Pub Date : 2024-02-26 DOI: 10.1002/ila2.33
Tetsuya Asakawa, Yi-Wei Tang, Hongzhou Lu
{"title":"From bench to bedside: Opportunities and challenges for iLABMED","authors":"Tetsuya Asakawa,&nbsp;Yi-Wei Tang,&nbsp;Hongzhou Lu","doi":"10.1002/ila2.33","DOIUrl":"https://doi.org/10.1002/ila2.33","url":null,"abstract":"<p>Since the new <i>iLABMED</i> was founded in June 2023, it has published three issues with 21 articles (till Dec 2023). As a journal majored in laboratory medicine, <i>iLABMED</i> also has to face many opportunities and challenges of laboratory medicine. This editorial summarized the main opportunities and challenges faced by <i>iLABMED</i>. The future prospects of laboratory medicine, which must be highlighted by <i>iLABMED</i> were also discussed based on a brief review of the current advances in laboratory medicine. <i>iLABMED</i> will continue to provide a useful platform for general-interested, insightful, and informative articles with high quality.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140291380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudomonas aeruginosa infections and improper storage conditions influence the performance of 1,3-β-d-glucan in diagnosis of invasive fungal infections 铜绿假单胞菌感染和不当储存条件影响 1,3-β-d 葡聚糖诊断侵袭性真菌感染的性能
iLABMED Pub Date : 2024-02-20 DOI: 10.1002/ila2.35
Zilan Wei, Jie Xu, Fang Yuan, Wendong Fang, Jiahui Wu, Youliang Wang, Shuiping Chen
{"title":"Pseudomonas aeruginosa infections and improper storage conditions influence the performance of 1,3-β-d-glucan in diagnosis of invasive fungal infections","authors":"Zilan Wei,&nbsp;Jie Xu,&nbsp;Fang Yuan,&nbsp;Wendong Fang,&nbsp;Jiahui Wu,&nbsp;Youliang Wang,&nbsp;Shuiping Chen","doi":"10.1002/ila2.35","DOIUrl":"https://doi.org/10.1002/ila2.35","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The association between 1,3-<i>β</i>-<span>d</span>-glucan (BDG) levels and infections caused by <i>Pseudomonas aeruginosa</i> or <i>Streptococcus pneumoniae</i>, and the stability of BDG under different storage conditions are unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Strains of <i>Pseudomonas aeruginosa</i> and <i>S</i>. <i>pneumoniae</i> were grown in medium and human serum. The BDG concentrations in culture supernatants were measured. The specificity and stability of BDG were also evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p><i>P</i>. <i>aeruginosa</i> produced high levels of BDG in Luria–Bertani medium (&gt;4 × 10<sup>4</sup> pg/mL) and human serum (527.0 pg/mL), whereas <i>S</i>. <i>pneumoniae</i> produced low levels of BDG in THY medium (175.6 pg/mL) and human serum (78.3 pg/mL). The BDG produced by these two bacteria was specifically degraded by 1,3-<i>β</i>-<span>d</span>-glucanase. BDG was degraded when stored at different temperatures, decreasing by 22.5% and 9.3% at −20°C and −70°C, respectively, for 63 days; by 30.7% at 4°C for 12 days; and by 12.6% and 22.0% at 37°C for 6 and 12 h.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>BDG false-positivity must be considered in patients with bacteremia caused by <i>P</i>. <i>aeruginosa</i> when diagnosing invasive fungal infection. Human serum samples for the BDG test in medical facilities should be tested as soon as possible or stored at low temperatures before testing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.35","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140291358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods 用于预测嵌合抗原受体 T 细胞疗法疗效的生物标志物及其检测方法
iLABMED Pub Date : 2024-02-16 DOI: 10.1002/ila2.31
Bo Zou, Yanzhou Song, Ning Li, Zhongyi Fan, Jie Li, Yuanzheng Peng, Wanshan Wei, Yuzi Zhang, Yinan Su, Xianmin Meng, Hongzhou Lu, Xingding Zhang, Xiaohua Tan, Qibin Liao
{"title":"Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods","authors":"Bo Zou,&nbsp;Yanzhou Song,&nbsp;Ning Li,&nbsp;Zhongyi Fan,&nbsp;Jie Li,&nbsp;Yuanzheng Peng,&nbsp;Wanshan Wei,&nbsp;Yuzi Zhang,&nbsp;Yinan Su,&nbsp;Xianmin Meng,&nbsp;Hongzhou Lu,&nbsp;Xingding Zhang,&nbsp;Xiaohua Tan,&nbsp;Qibin Liao","doi":"10.1002/ila2.31","DOIUrl":"10.1002/ila2.31","url":null,"abstract":"<p>Cancer immunotherapy has emerged as the fourth most prevalent approach to tumor treatment, alongside surgery, radiotherapy, and chemotherapy. After several decades of development, chimeric antigen receptor T (CAR-T) cell therapy, a promising branch of adoptive T-cell therapy, has demonstrated superior efficacy and safety in comparison to other cell therapies in the treatment of cancer. At present, CAR-T cells are predominantly used to treat hematological malignancies, although their application in solid tumors is being readily investigated. Although numerous studies have examined the biomarkers associated with the safety of CAR-T cell therapy, few have evaluated predictors of CAR-T cell therapeutic efficacy. Thus, the primary objective of this review article was to provide a comprehensive overview of the factors predicting the efficacy of CAR-T cell therapy, with a particular focus on biomarkers and their detection methods.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.31","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139960910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of new diagnostic targets for hepatitis B virus-induced liver fibrosis 确定乙型肝炎病毒所致肝纤维化的新诊断靶标
iLABMED Pub Date : 2024-01-02 DOI: 10.1002/ila2.30
Ying Wang, Shuo Qin, Meng Yang, Xiaoling Wang
{"title":"Identification of new diagnostic targets for hepatitis B virus-induced liver fibrosis","authors":"Ying Wang,&nbsp;Shuo Qin,&nbsp;Meng Yang,&nbsp;Xiaoling Wang","doi":"10.1002/ila2.30","DOIUrl":"10.1002/ila2.30","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Liver fibrosis is a transitional stage from hepatitis to cirrhosis, and hepatitis B virus (HBV) is the most common cause of liver disease. Transcriptome sequencing technology and bioinformatics analysis are increasingly being used to screen diagnostic targets for liver fibrosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The GSE171294 dataset of HBV-induced liver fibrosis tissue and normal tissue was obtained from the Gene Expression Omnibus (GEO) public database and used to screen for differentially expressed mRNAs using R software. mRNAs with |log fold change| &gt;1 and <i>p</i> &lt; 0.05 were considered to be differentially expressed. A heat map was drawn to visualize the expression patterns of the differentially expressed mRNAs. To screen for candidate target mRNAs, the differentially expressed mRNAs were annotated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analysis. Finally, a protein–protein interaction (PPI) network was constructed to analyze the relationships between the differentially expressed mRNAs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 243 differentially expressed mRNAs were identified (<i>p</i> &lt; 0.05); 129 were up-regulated and 114 were down-regulated. The up-regulated and down-regulated mRNAs were significantly enriched in 16 and 8 KEGG pathways, respectively. The enriched KEGG pathways included Salmonella infection, Protein processing in the endoplasmic reticulum, IL-17 signaling pathway, and Aldosterone synthesis and secretion. The enriched GO terms were related mainly to cell proliferation, apoptosis, endoplasmic reticulum complex assembly, and myosin synthesis. The PPI network contained 161 nodes and 120 pairs of interactions. The top 10 key nodes were <i>CAV1, CD4, NR3C1, PDIA3, EZR, IRF4, SOX9, HSP90AB1, CD40,</i> and <i>SEC13</i>.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Bioinformatics analysis of the transcriptome sequencing data in the GSE171294 dataset identified <i>CD4</i>, <i>NR3C1</i>, and <i>EZR</i> and other genes at key nodes as new targets for the treatment of liver fibrosis caused by HBV. These results provide new insights for HBV-induced liver fibrosis research and clinical treatment.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.30","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139453544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic COVID 大流行前后肺炎支原体感染的流行特征概述
iLABMED Pub Date : 2023-12-18 DOI: 10.1002/ila2.27
Hongmei Sun, Li Xiao
{"title":"Overview of the epidemic characteristics of Mycoplasma pneumoniae infection around COVID pandemic","authors":"Hongmei Sun,&nbsp;Li Xiao","doi":"10.1002/ila2.27","DOIUrl":"https://doi.org/10.1002/ila2.27","url":null,"abstract":"<p><i>Mycoplasma pneumoniae</i> (<i>M. pneumoniae</i>) is a cell wall-less respiratory pathogen causing community-acquired pneumonia and extrapulmonary manifestations. It is transmitted through close contact and shows periodic regional outbreaks. The coronavirus disease (COVID-19) pandemic interfered with the global spread of <i>M. pneumoniae</i>. A large-scale post-COVID outbreak is currently ongoing in China. To help physicians better understand and manage this epidemic, we provide this review summarizing current knowledge on the pathogenesis, epidemic characteristics, macrolide resistance, diagnostic methods, and clinical treatment strategies for this pathogen.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.27","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139041982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The important role of skin biopsies in the diagnosis of mpox 皮肤活检在麻风病诊断中的重要作用
iLABMED Pub Date : 2023-12-09 DOI: 10.1002/ila2.29
Wun-Ju Shieh
{"title":"The important role of skin biopsies in the diagnosis of mpox","authors":"Wun-Ju Shieh","doi":"10.1002/ila2.29","DOIUrl":"10.1002/ila2.29","url":null,"abstract":"<p>Skin biopsy is an important, efficient, and safe procedure for diagnosing infectious dermatopathy, including mpox. An optimal approach of laboratory diagnosis of mpox should include obtaining a skin punch biopsy from pertinent lesions for pathologic evaluation in addition to conventional swab or scrap for molecular testing.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.29","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138586130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutating Escherichia coli caused multiple organ dysfunction syndrome 变异大肠杆菌导致多器官功能障碍综合征
iLABMED Pub Date : 2023-12-09 DOI: 10.1002/ila2.26
Lihua Qi, Wencheng Xue, Xuelin Liu, Shaofu Qiu, Jie Liu
{"title":"Mutating Escherichia coli caused multiple organ dysfunction syndrome","authors":"Lihua Qi,&nbsp;Wencheng Xue,&nbsp;Xuelin Liu,&nbsp;Shaofu Qiu,&nbsp;Jie Liu","doi":"10.1002/ila2.26","DOIUrl":"10.1002/ila2.26","url":null,"abstract":"<p>Pathogenic <i>Escherichia coli</i> is of great concern in the clinical setting. But few reports have demonstrated the variation in disease course. We present a severe case of multiple organ dysfunction syndrome caused by <i>E. coli</i> infection. Pathogens isolated from blood and urine samples harboured many virulence factors. Whole-genome sequencing and conventional analyses showed that the isolates experienced beneficial variations, both genetically and phenotypically, during the disease course. These findings showed that <i>E. coli</i> can cause systemic symptoms and informed us of the importance of assessing the reasons for such variations in pathogens occurring in vivo.</p>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.26","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138585754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease 血清免疫特征在克罗恩病早期诊断中的临床验证
iLABMED Pub Date : 2023-12-06 DOI: 10.1002/ila2.28
Xianzong Ma, Wenyu Zhang, Xin Wang, Lang Yang, Juan Jiao, Yan Jia, Dezhi Wang, Junfeng Xu, Peng Jin, Mingjie Zhang, Shirong Li, Yuanming Pan, Jianqiu Sheng
{"title":"Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease","authors":"Xianzong Ma,&nbsp;Wenyu Zhang,&nbsp;Xin Wang,&nbsp;Lang Yang,&nbsp;Juan Jiao,&nbsp;Yan Jia,&nbsp;Dezhi Wang,&nbsp;Junfeng Xu,&nbsp;Peng Jin,&nbsp;Mingjie Zhang,&nbsp;Shirong Li,&nbsp;Yuanming Pan,&nbsp;Jianqiu Sheng","doi":"10.1002/ila2.28","DOIUrl":"10.1002/ila2.28","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The search for biomarkers suitable for early diagnosis of Crohn's disease (CD) is challenging. This study investigated the efficacy of serological markers for the early diagnosis of CD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This was a retrospective nested cohort study. Indirect immunofluorescence and enzyme-linked immunosorbent assay were used to detect ASCA IgG, ASCA IgA, AYMA IgG, AYCA IgG, FI2Y IgG, p-ANCA IgG, GAB IgG and PAB IgG in patient serum samples.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The positive rates of ASCA IgG, ASCA IgA, AYMA IgG, AYCA IgG, FI2Y IgG, p-ANCA IgG, GAB IgG and PAB IgG in patients with early CD, advanced CD and other intestinal diseases were 37.0% versus 56.8% versus 27.8%; 3.7% versus 20.5% versus 19.4%; 14.8% versus 2.3% versus 2.8%; 25.9% versus 9.1% versus 8.3%; 18.5% versus 15.9% versus 8.3%; 0.0% versus 2.8%, 18.5%; 13.6% versus 18.2% versus 16.7%; and 7.4% versus 20.5% versus 0.0%, respectively. The positive rates of ASCA IgG, AYCA IgG and PAB IgG were significantly different among the three groups (<i>p</i> &lt; 0.05). In 85.2% of early CD patients, at least one antibody was detected 1 year before diagnosis. The sensitivity of the ASCA/AYMA/AYCA/FI2Y/GAB combination for early diagnosis was 85.2%. The sensitivity of the ASCA/AYMA/AYCA/FI2Y/GAB/PAB/PANCA combination for differentiating CD from other diseases was 87.3%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>ASCA IgG and AYCA IgG have potential value in identifying the course of CD. AYCA IgG may be a potential marker for the early diagnosis of CD, and ASCA IgG indicates an advanced stage. The combination of ASCA, AYMA, AYCA, FI2Y, and GAB improves early diagnostic accuracy of CD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100656,"journal":{"name":"iLABMED","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ila2.28","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138596565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信